Overview
Takayasu Mori practices in Tokyo, Japan. Mori and is rated as an Elite expert by MediFind in the treatment of Pseudohypoaldosteronism Type 1. Their top areas of expertise are Pseudohypoaldosteronism Type 1, Pseudohypoaldosteronism Type 2, Gitelman Syndrome, Liver Embolization, and Nephrectomy.
Their clinical research consists of co-authoring 202 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Pseudohypoaldosteronism Type 1.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Autosomal Dominant Polycystic Kidney Disease
- Autosomal Dominant Tubulointerstitial Kidney Disease
- Bartter Syndrome
- Gitelman Syndrome
- High Potassium Level
- Low Potassium Level
- Advanced
- Alport Syndrome
- Chronic Kidney Disease
- Diabetes Insipidus (DI)
- Glomerulonephritis
- Hypertension
- Membranoproliferative Glomerulonephritis
- Experienced
- Acute Kidney Failure
- Aortic Dissection
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Autonomic Dysreflexia
- Autosomal Recessive Polycystic Kidney Disease
- Calcinosis